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Abstract.  The actin/myosin II cytoskeleton and its 
role in phagocytosis were examined in primary cul- 
tures of dog thyroid cells. Two (19 and 21  kD) phos- 
phorylated light chains of myosin (P-MLC) were 
identified by two-dimensional gel electrophoresis of 
antimyosin immunoprecipitates,  and were associated 
with the Triton X-100 insoluble, F-actin cytoskeletal 
fraction.  Analyses of Triton-insoluble and soluble 
32pO4-prelabeled  protein fractions indicated that TSH 
(via cAMP) or TPA treatment of intact cells decreases 
the MLC phosphorylation state. Phosphoamino acid 
and tryptic peptide analyses of 32p-MLCs  from basal 
cells showed phosphorylation primarily at threonine 
and  serine residues;  most of the [32p] appeared as- 
sociated with a peptide containing  sites typically phos- 
phorylated by MLC kinase.  Even in the presence of 
the agents which induced dephosphorylation,  the phos- 
phatase inhibitor,  calyculin A, caused a  severalfold in- 
crease in MLC phosphorylation at several distinct ser- 
ine and threonine  sites which was also associated with 
actomyosin and cell contraction.  Phosphorylation of 
cell homogenate proteins or the cytoskeletal fraction 
with [~/-32p]ATP indicated that Ca  2+, EGTA, or 
trifluoperazine (TFP) has little effect on the phos- 
phorylation of MLC. Both fluorescent phalloidin and 
antimyosin staining  of cells showed distinct dorsal and 
ventral stress fiber complexes which were disrupted 
within 30 min by TSH and cAMP; TPA appeared to 
cause disruption of dorsal, and rearrangement  of ven- 
tral complexes. Concomitant with MLC dephosphory- 
lation and stress fiber disruption,  TSH/cAMP, but not 
TPA, induced dorsal phagocytosis of latex beads. 
While stimulation of either A  or C-kinase disrupts 
dorsal stress fibers and rearranges  actomyosin, another 
event(s) mediated by A-kinase appears necessary for 
phagocytic activity. 
N 
ONMUSCLE cells,  including  thyroid,  contain  acto- 
myosin complexes that  can provide the mechano- 
chemical framework for a variety  of dynamic pro- 
cesses such as cell shape changes, surface receptor mobility, 
secretion, and phagocytosis (14, 18, 30, 37). Similarities  ex- 
ist between nonmuscle and smooth muscle actomyosin struc- 
tural components, and their regulation  (31). Typically, myo- 
sins contain a regulatory light chain phosphoprotein (myosin 
light  chain,  MLC)  1 ranging  between 18 and 22 kD (3, 21, 
31); both serine 19 and threonine  18 residues of MLC can 
be phosphorylated (11, 38), although  the rate and extent of 
threonine phosphorylation has been observed to be less than 
that of serine (11, 23). In cardiac (22),  slow skeletal muscle 
(48), myeloid leukemia (42), macrophage (53), platelet (28), 
and bovine brain (36) cells, phosphorylated MLC isoforms 
have been identified  by electrophoretic resolution. 
1.  Abbreviations  used in  this paper:  CHES, 2-(cyclohexylamino)ethane- 
sulfonic acid; F-actin, filamentous actin; MLC, myosin light chain; MLCK, 
MLC kinase; P-MLC, phosphorylated MLC; 2-13, two dimensional; TPA, 
12-o-tetradecanoyl-phorbol-13-acetate;  TSH, thyroid-stimulating  hormone 
(or thyrotropin). 
MLC  phosphorylation  plays  a  key  role  in  regulating 
actin-myosin interactions  and contraction in both smooth 
muscle and nonmuscle cells (3,  13, 54). Dephosphomyosin 
exists  mostly in a dimeric  form,  whereas phosphomyosin 
forms bipolar filaments  (35, 45, 49) with increased affinity 
for filamentous  actin and increased myosin ATPase activity 
(2, 35, 40, 46, 47). Phosphorylation of the MLC serine 19 
residue occurs via a specific Ca2+/calmodulin-stimulated ki- 
nase (MLC kinase;  MLCK) (1, 4, 38, 56), whereas a Ca  2+- 
independent  kinase(s) phosphorylates at a threonine  residue 
as shown in brain (36), for example.  Protein kinase C phos- 
phorylates MLC, but at serine 1 and 2, and also threonine 
9, which in vitro,  can suppress ATPase activity stimulated 
by serine 19 phosphorylation (25). 
Presently, little evidence exists for regulation  of the MLC 
phosphorylation state at the phosphatase level,  although  a 
type-1 phosphatase appears to be involved in fibroblasts (16). 
There is consensus that increases in cAMP can antagonize 
MLC phosphorylation and contraction  (7,  9,  12,  33, 43). 
Phosphorylation  of  MLCK  by  A-kinase  (9,  12,  33)  or 
C-kinase (24) inhibits  its Ca2+/calmodulin-stimulated  activ- 
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appears to be responsible for cAMP inhibition of contrac- 
tion in retinal cones (9), and MLC dephosphorylation and 
stress  fiber disruption in fibroblasts (33).  Often, agonists 
that stimulate secretion and changes in cell shape will ele- 
vate  intracellular  Ca  2+  and concomitantly increase  MLC 
phosphorylation and actomyosin formation, as observed in 
platelets  (17). In  contrast,  the  thyroid agonist,  (thyroid- 
stimulating hormone, TSH), elevates cAMP levels which in- 
duces phagocytosis of colloid or latex beads by thyroid cells 
(50), and causes a more rounded cell morphology, and acute 
disruption of F-actin complexes in these cultures (37, 41, 52, 
55). It is not clear whether the C-kinase stimulating phorbol 
ester,  12-o-tetradecanoyl-phorbol-13-acetate  (TPA), can pro- 
mote phagocytosis, although epithelial cell shape changes 
and rearrangement of F-actin have been observed (29, 41, 
44). The mechanisms involved in these cAMP and phorbol 
ester-mediated processes are unknown. 
Our previous studies have shown that both TSH via cAMP 
(26) and TPA (27), decrease the phosphorylation state of 19- 
and 21-kD proteins in cultured dog thyroid cells. While these 
proteins appeared to be MLCs, inhibitors of intracellular 
Ca  2+ or calmodulin failed to decrease the phosphorylation 
state of these proteins, thus questioning the involvement of 
a  classic  Ca2+/calmodulin  stimulated ldnase.  In the pres- 
ent report, immunoprecipitation combined with two dimen- 
sional (2-D) PAGE analysis has identified these proteins as 
MLCs which in basal cells are primarily phosphorylated at 
threonine and serine sites, and are associated with the deter- 
gent-insoluble cytoskeleton. Phosphorylation is independent 
of  Ca2+/calmodulin, and unlike  the Ca2+/calmodulin MLCK 
(9, 12, 33),  is  not directly  inhibited  by cAMP  and A-kinase 
in vitro.  However, regulation  of the agonist-induced MLC 
dephosphorylation  at a protein phosphatase  I and/or 2A 
level  is indicated  since  the phosphatase inhibitor,  calyculin 
A, increases MLC  phosphorylation scveralfold  over basal 
levels  even in  the  presence of  agents  which have induced de- 
phosphorylation. Both kinasc and phosphatasc activity  are 
associated with the detergent-insoluble cell fraction. The 
data show that  while TSH/cAMP  and TPA-induced MLC 
dephosphorylations are associated  with stress  fiber  disrup- 
tion, the A-kinasc, but not C-kinasc, pathway significantly 
induces phagocytosis of latex  beads. 
Materials and Methods 
~ssue Preparations and Incubations  for 
p2P]Phosphate Labeling 
Cultures of dog thyroid follicle cells were prepared as previously described 
(37). Primary cultures were grown at 37°C in Coon's modified Ham's F-12 
medium supplemented with 0.5 % bovine calf serum (supplied by the Tissue 
Culture Core Laboratory of the Diabetes and Endocrinology Research Cen- 
ter of Baylor College of Medicine, Houston, TX), insulin (10 IZg/mi), cor- 
tisol  (3.6  /~g/ml),  transferin  (5  ~g/ml),  glycyl-L-histidyl-L-lysine  (0.2 
~g/rnl), somatostatin (10/tg/ml), and 1 mU/ml TSH (NIDDK-bTSH,  10-30 
U/mg, supplied by the Pituitary Hormone Distribution Program of the Na- 
tional Institutes of Diabetes,  Digestive  and Kidney  Diseases,  Bethesda, 
MD)  in a  water-saturated  atmosphere of 5 % CO2.  Medium containing 
TSH was designated 6H. Confluent cells were generally used within 3 wk 
of culture, and before use were grown in Coon's medium without TSH (5H) 
for 48 h. When fibroblasts from thyroid tissue were used,  1-wk cultures 
grown in 5H medium were allowed to become routinely acidic. This proce- 
dure selectively  caused thyroid cell detachment and cultures subsequently 
became predominantly fibroblastic. 
Cultured thyroid cells (500-700 pg protein/35-mm dish) were incubated 
in 5% CO2/air with 0.15 mCi/ml [32p]orthophosphoric  acid (supplied  by 
the Molecular Endocrinology Core Laboratory of the Diabetes and En- 
docrinology Research Center of Baylor College of Medicine, Houston, TX) 
in phosphate-free  Tyrode's buffer  (15 mM Hepes,  136 mM NaC1, 2 mM 
KC1, 10 mM Na2CO3, 1 mM MgC12, 1 mg/ml glucose, 0.1 mM nonessen- 
tial and essential  amino acids, pH 7.4-7.5) at 37°C for 120 rain. This was 
previously  found to maximally label the intraceilular [3,-32p]ATP pools 
(26).  Labeled cells were washed with the above buffer and incubated at 
37°C in Tyrode's buffer with or without various agents and for the times in- 
dicated in the figures and table. 
Separation of the Cytoskeletal and Cytosol Fractions 
At appropriate times, incubations were terminated by removal of the buffer 
and a brief wash at 2°C with cytoskeletal lysis buffer containing 40 mM 
sodium pyrophosphate,  20 raM  potassium phosphate,  10 mM  sodium 
molybdate, and 3 mM EGTA, pH 7.4. Ceils were then extracted by incuba- 
tion in the above solution made 1% Triton X-100 (Sigma Immunochemicals, 
St. Louis, MO) for 3 rain at 2°C. The material remaining on the dish after 
removal of the buffer (17, 26, 27) was considered as the detergent-insohible 
cytoskeletal fraction; protein in the buffer fraction was considered as the 
cytosol fraction. Approximately 60% of the total protein was extracted and 
40% remained in the cytoskeletal-containing fraction. 
Myosin Extraction and lmmunoprecipitation 
Myosin was  extracted  from [32p]phosphate-labeled  cytoskeletons  by in- 
cubating the detergent-insoluble  material in 0.25 mi of extraction buffer 
containing 100 mM sodium pyrophospbate,  50 mM NaF, 5 mM EGTA,  15 
mM 2-mercaptoetbanol, 1.5 mM PMSE  10 mM MgCI2/ATP, 0.5 M KCI, 
and 10% glycerol,  pH 8.8, at 4°C for 30 min. The buffer was removed and 
diluted fourfold  with 50 mM "Iris,  190 mM NaC1, 6  mM EDTA,  0.1% 
trasylol, 1.25 % Triton X-100, pH 7.4, containing aliquots of thymus myosin 
antibody (kindly supplied  by Dr.  John Kendrick-Jones,  Cambridge, En- 
gland), and incubated for 90 rain at 2°C. After a brief microfuge clarifica- 
tion spin,  100 /tl of protein A-Sepbarose CL-4B (Pharmacia, Uppsala, 
Sweden): H20 suspension (1:1) was added to the supernatant and incubated 
for 40 min at 25°C  with shaking.  The protein A-Sepharose was  then 
pelleted and washed twice with 1 ml of dilution buffer and 1.5 mM PMSF 
at 25°C for 30 rain each. A third wash was done in dilution buffer without 
Triton, and the pelleted protein A-Sepharose was incubated in isoolectric 
focusing  sample  buffer  containing 9  M  urea,  4%  NP-40  (Sigma  Im- 
munochemicals),  2%  2-mercaptoethanol, 4%  3.5-10  ampholine (LKB 
Bromma, Sweden) for 2 h at 25°C. ARer protein solubilization,  the sepba- 
rose was pelleted and the supernatant subjected to 2-D electrophoresis.  For 
analysis  of the crude extracted myosin fraction, the 0.25  ml sample was 
diluted with 1.8 ml of urea isoelectric  focusing buffer, incubated at 25°C 
for 2 h and concentrated using Centricon-10  microconcentrators (Amicon 
Corp., Danvers,  MA). 
Gel Electrophoretic  Analyses 
When I-D SDS-PAGE was used, protein was solubilized by boiling for 3 
rain in 2%  SDS,  5%  2-mercaptoethanol, 10%  glycerol,  0.002%  brom- 
phenol blue, and 62.5 mM Tris-HC1, pH 6.8. When homogenates were ana- 
lyzed, 4x sample buffer was used.  Samples  (30-60 Izg) were subjected to 
electrophoresis, with 3 % acrylamide (Bio Rad Labs, Hercules,  CA) in the 
stacking gel and a 5-18 % acrylamide gradient in the resolving gel according 
to the method of Laemmii (32). Two dimensional PAGE was performed ac- 
cording to the methods of Anderson et al. (5) and Dunbar 05). Samples 
were solubilized in either 9 M urea, 4 % NP-40, 2 % 2-mercaptoethanol, 4 % 
3.5-10  ampholine,  or  0.05  M  2-(cyclohexylamino)ethane-sulfonic  acid 
(CHES) (Calbiochem Corp., San Diego, CA), 2% SDS, 10% glycerol,  2% 
2-mercaptoethanol (5, 15), and after isoelectric focusing,  resolved accord- 
ing to molecular weight on either 11% acrylamide or 5-20% acrylamide 
gradient gels.  For homogenate studies,  reactions were terminated and the 
protein sohibilized by addition of4x CHES-SDS  sample buffer and boiled 
for 3 rain. All gels were stained with Coomassie blue in methanol, H20, 
acetic acid (5:5:1),  destalned, dried, and subjected to autoradiography at 
-70°C using XAR-5 or XS-5 film (Eastman KDdak Co., Rochester,  NY) 
and two Dupont lighting plus BE intensifying screens (Dupont/NEN, W'fl- 
mington, DE).  The relative amounts of radioactivity in phosphoproteins 
were determined by integration of densitometric scans of autoradiograms 
using a Quick Scan, Jr. TLC plus (Helena Laboratories, Beaumont, TX). 
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Phosphoamino Acid Analyses 
Cultured  thyroid  cells  in  35-mm dishes were  loaded  with 0.8  mCi/ml 
[32P]phosphate in Tyrode's buffer without CaC12 for 2 h at 37°C, washed 
and incubated without or with 40 mU/ml TSH, 0.2 #M TPA, or 400 nM 
calyculin A (L C Services Corp., Woburn, MA) for 20 rain. Cells were then 
lysed as described above, and cytoskeletal fractions were subjected to 2-D 
electrophoresis and the Coomassie-stained MLC spots excised from the 
gels. In vitro phosphorylation of ATP-extracted cytoskeletal myosin using 
purified C-kinase (Calbiochem Corp.) was done to provide a standard for 
identifing MLC tryptic phosphopeptides and phosphorylation, sites. The 
Triton-insoluble cytoskeletai fraction was incubated for 4 min at 2°C in 220 
t~l of a buffer containing 30 mM Tris-HCl, pH 7.5,  1.2 mM CaCI2,  5 mM 
MgCI2, 1 mM EGTA, 45 mM KC1, 0.5raM DTT, 0.5 mM ATP, 150 #g/ml 
phosphatidylserine (Sigma Immunochemicals, St.  Louis,  MO),  0.2  #M 
TPA. Buffer containing extracted myosin was removed, and to 50-#1 ali- 
quots was added 0.1  #g protein kinase C  and  ['y-32P]ATP (2,000  cpm/ 
pmol). Phosphorylation was carried out at 25°C for I h, and reactions were 
terminated by the addition of 4×  SDS sample buffer.  [32p]MLC  from ex- 
cised gel pieces was digested first by washing the pieces in 50 then 80% 
methanol followed by 20 mM ammonium bicarbonate (8). Gels were in- 
cubated in 50 mM ammonium bicarbonate containing 20 #g TPCK trypsin 
(Worthington Biochemical Corp., Freehold, NJ) at 37°C for 2 h. Two fresh 
trypsin aliquots were added 2 h apart, followed by an overnight incubation. 
Peptide digest solutions were then lyophilized, and the phosphotryptic pep- 
tides resolved essentially as described (28). Electrophoresis was performed 
on cellulose thin-layer sheets 20  x  20 cm/0.1 mm thick (E.  Merck Re- 
agents, Darmstadt, W. Germany) in acetic acid/formic acid/H20 (15:5:80) 
for 40 rain at 700 V, followed by chromatographic resolution in the second 
dimension in n-butyl aicohol/pyridine/acetic acid/H20  (156:120:24:96). 
Phosphopeptide  spots  were  detected  by  autoradiography  with  Kodak 
XAR-5 film (Eastman Kodak Co.), and the phosphoamino acids determined 
on samples eluted from the chromatographs. Lyophilized peptides were dis- 
solved in 6 N HCI (200 #1), heated at 105°C for 2 h, and lyophilized again. 
The  hydrolysates were dissolved in  1420 containing  1  mg/ml  each of 
P-serine, P-threonine, and P-tyrosine markers (Sigma Immunochemicals), 
applied to cellulose thin-layer sheets, and subjected to either ascending 
chromatography in isobutyric acid/0.5 M  NH4OH (5:3 vol/vol), or elec- 
trophoresis for 2 h at 750 V in the above acetic acid/formic acid buffer using 
silica gel plates. Phosphoamino acid spots detected by ninhydrin staining 
and autoradiography could also be cut out to determine the relative [32p] 
content by liquid scintillation counting. 
Analysis of Protein Phosphatase Activity 
Cells grown in  16-ram wells were prelabeled with [32p]phosphate,  and 
then incubated with 400 nM calyculin A (LC Services Corp., Woburn, MA) 
at 37°C either alone, or before and after treatments with the various agents 
which induce MLC dephosphorylation. Incubation reactions were stopped 
by lysing cells at 2°C as described above, and the detergent-insoluble frac- 
tions were washed with CLB and prepared for gel electrophoresis by addi- 
tion of SDS sample buffer. 
To  examine phosphatase activity  in  situ,  cells were prelabeled with 
[32P]phosphate, lysed, and the cytoskeletons incubated for 10 min at 30°C 
in  100 #1 of 50 mM Tris-HCl, 50 mM NaC1,  5.0 mM MgC12, 1.5 mM 
PMSF, 1 mM DTT,  pH 7.0. Reactions were terminated by addition of 4x 
CHES-SDS sample buffer, boiled, and subjected to 2-D gel electropho- 
resis. 
Analysis of Protein Kinase Activity 
Four confluent 35-mm dishes of thyroid cells were washed at 2°C with 20 
mM Hepes,  1.5 mM PMSF, 5 mM MgCI2,  1 mM DTT,  pH 7.4 (kinase 
buffer). Cells were then collected with a rubber policeman in 2 ml of kinase 
buffer, homogenized by 10 passes with a Teflon-to-glass homogenizer, soni- 
cated 15  s  with a  W-380 Heat Systems sonicator (Heat Systems-Ultra- 
sonics,  Inc.,  Farmingdale,  NY)  (80%  output  power),  and  further 
homogenized as above. Fractions were then made 0.1 mM CaCI2,  5 mM 
EGTA, 50 #M W7 (Rikaken Co. Ltd., Nagoya, Japan) or TFP (Sigma Im- 
munocbemicals), or 20 #M cAMP. Homogenate aliquots of 70 #1 were in- 
cubated at 33°C with 10 #1 of 4 mM [3,-32p]ATP (200 cpm/pmol) (synthe- 
sized by the Molecular Endocrinology Core Laboratory of  the Diabetes and 
Endocrinology Research Center of Baylor College of Medicine). After 3 
min, reactions were terminated by addition of 4×  CHES-SDS 2-D elec- 
trophoresis sample buffer and boiling. The same procedure was done using 
thyroid follicles isolated as described previously (37). The fibroblast sam- 
ples were analyzed by 1-D electrophoresis. For analysis of protein kinase 
activity associated with the cytoskeletons, cells were lysed with 1% Triton 
X-100 in kinase buffer and then washed with kinase buffer alone at 2°C. The 
insoluble material on the dishes was then incubated for 3 rain at 24°C in 
kinase buffer containing [7-32p]ATP  and the above agents. Reactions were 
terminated by addition of  4× CHES-SDS sample buffer as above, and sam- 
pies were subjected to 2-D gel electrophoresis. 
Fluorescent Staining and Light Microscopy 
Isolated thyroid follicles were grown on glass coverslips for 6-14 d  to 
confluency in plastic petri dishes containing 6H Coon's media described 
above. Before experimentation, cells were incubated in 5H (-TSH) media 
for 1-2 d to achieve a basal, unstimulated condition. After this period, the 
various agents were added, and cells were further incubated for the indi- 
cated times. Coverslips were then removed, washed in PBS, and fixed for 
5 rain with 1% glutaraldehyde (Ted Palla, Inc., Redding, CA) in PBS at 
25°C. Cells were permeabilized with 0.5% Triton X-100 in PBS for 10 rain 
at 25°C, and autofluorescence quenched with 1 mg/ml sodium borohydride 
in PBS on ice. After blocking with 1% BSA, cells were incubated at 25°C 
for 30 min with rhodamine-phaUoidin (Molecular Probes, Inc., Eugene, 
OR)  diluted in blocking solution,  washed in PBS,  and coverslips were 
mounted on glass slides with PBS containing Airvol (Air Products & Chem- 
icals, Inc., Allentown, PA). For localization of myosin, cells were first per- 
meabilized at 2°C with 1% Triton as described above for phosphorylation 
studies. Coverslips were then immersed in -20°C methanol for 8 min to 
fix the detergent-insoluble cytoskeletal protein.  After blocking with  1% 
BSA in PBS, coverslips were incubated overnight at 25°C with antibody 
against human platelet myosin (Biomedical Technology Inc., Stoughton, 
MA),  followed by a 2-h incubation with rhodamine goat anti-rabbit IgG 
(Jackson ImmunoResearch Laboratories Inc., West Grove, PA).  All cells 
were  examined  with  a  Zeiss  Axiophot  microscope,  and  photographs 
recorded on Tri-X Pan film (Eastman Kodak Co.). 
Phase-Contrast Video Microscopy 
The movement of cells was visualized using a Zeiss IM inverted microscope 
with  a  DAGE-72  camera  interfaced with  a  Panasonic AG  6720  video 
recorder. Regions from a confluent monolayer of cells in 5H media were 
first recorded to assess unstimulated cell behavior. Cells were maintained 
at 37°C by fan heating and gassed with CO2 to control pH of the media. 
After the addition of TPA to 0.2  #M,  a  field of cells was immediately 
selected, and typically recordings were done for 90 min. Printed images of 
cells at various time intervals were produced from the tape by a Sony UP- 
5000 video printer. 
Scanning and Transmission EM and Analysis 
of Bead Ingestion 
Thyroid cells cultured on glass coverslips were treated with a 0.04 % suspen- 
sion of 1 #m carboxylated latex beads (Polysciences Inc., Warrington, PA) 
and agents in 5H media at 37°C for 30 min. Cells were then washed several 
times with PBS, and fixed with 2.5% glutaraldehyde in 0.1 M cacodylate/ 
0.2 M sucrose buffer,  pH 7.2, for 1-2 h at 25°C. Samples were postfixed 
for  1 h  in  1%  OsO4,  dehydrated in graded ethanols, and critical point 
dried. Specimens were sputter coated with platinum, and examined with a 
CM-12 Philips electron microscope. Scanning EM micrographs were ob- 
tained in secondary and backscattered modes, and were digitized using a 
Synergy Framestore and Synoptics software on a PC. Images were printed 
with a  Sony UP-5000 video printer. 
The relative extent of latex bead ingestion induced by TSH and TPA was 
determined in cells prepared for transmission EM analysis of  ultrastructure. 
Cells were plated in 60-mm Lux Permanox culture dishes (Electron Micros- 
copy Sciences, Fort Washington, PA), and grown to confluency. Cells in 5H 
media for 1-2 d were then exposed to a 0.04% suspension of I #m carbox- 
ylated latex beads containing 40 mU/ml TSH, 0.2/~M TPA or no agent (con- 
trol) for 30 min at 37°C. Surface beads were removed by washing several 
times with PBS, and cells were fixed in 2.5% glutaraldehyde in PBS for 2 h 
at 25°C. Cells were then postfixed in 1% OsO4,  dehydrated with graded 
ethanols, and embedded in Spurr's epoxy resin (Ted Pella, Inc.). For trans- 
mission EM analysis, O.08-#m vertical sections were prepared, stained with 
Reynolds lead and uranyl acetate, mounted on form,  car-coated copper slot 
grids, and examined with a Philips 410 electron microscope. Bead ingestion 
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mounted on glass slides, and examined  using phase contrast microscopy 
(100  × objective)  on a Zeiss  Axiophot  microscope.  To increase  the accuracy 
of determining  the relative  extent  of bead ingestion  by cells under various 
conditions, sections  were  cut 70 #m apart so that each  cell  region  examined 
(usually 2,500 from each treatment) was from a different  cell. 
Results 
Identification of Two Phosphorylated 
Myosin Light Chain Species by ATP Extraction and 
Antimyosin Immunoprecipitation 
Previous analyses  (26,  27)  of cultured thyroid cell  [32p]_ 
phosphoproteins associated with the Triton X-100 insoluble 
fraction revealed two proteins of 19 and 21  kD which ap- 
peared to be MLCs. To more definitively identify MLC, 2-D 
PAGE was used to analyze cytoskeletal fractions extracted 
with buffer containing ATP/KC1,  which dissociates myosin 
from F-actin.  After extraction, the majority of [32P]phos- 
phoproteins of 19 and 21 kD, pI 4.9-5.1, are present in the 
extract and not in the residual cytoskeletal fraction (data not 
shown). The extract was further subjected to immunoprecip- 
itation using antiserum against thymus myosin. Fig. 1 shows 
a 2-D PAGE autoradiogram of the immunoprecipitate from 
the myosin extraction buffer fraction. Only two [32p]phos- 
phoproteins of 19 and 21 kD are observed in the immunopre- 
cipitate,  thus identifying these proteins as  light chains of 
myosin. When one tenth of the antiserum was used for im- 
munoprecipitation,  the  radioactive proteins  were propor- 
tionaUy reduced (data not shown). The reason for the lesser 
Figure 1. 2-D SDS-PAGE  analysis of phosphoproteins immunopre- 
cipitated  with  anti-thymus  myosin serum.  Cytoskeletons  from 
[32P]phosphate-labeled thyroid cells were extracted with myosin 
extraction buffer and the extracted material immunoprecipitated 
with antimyosin serum and subjected to 2-D PAGE (see Materials 
and Methods). Acidic pH region is left, basic pH region is fight. 
Black bars on left, bottom to top represent 21.5-, 31-, 45-, and 66.2- 
kD molecular mass markers. 
amount of radioactivity associated with the 19-kD species is 
unknown since nearly equal radioactivity is observed when 
labeled cytoskeletons are immediately solubilized for elec- 
trophoresis. 
TSH and TPA Induce Dephosphorylation of 
Cytoskeletal MLC 
Figs. 2, A and B are autoradiograms of cytoskeletal and cy- 
tosolic  [32p]phosphoproteins,  respectively, prepared  from 
control, "basal" thyroid cells. Greater than 90 % of the radio- 
activity associated with the p2p]phospho-MLCs (32p-MLCs) 
is  found  in  the  detergent-insoluble cytoskeletal  fraction. 
Previous  determinations  of intracellular  [~-32p]ATP  spe- 
cific activity and stoichiometry of insoluble  19-kD/21-kD 
protein phosphorylation show that under basal conditions, 
this [~2p] radioactivity associated with MLC represents be- 
tween 0.8-0.9 mol phosphate/mol light chain protein (26, 
27).  After  treatment  of intact,  prelabeled  cells  with  40 
mU/ml TSH for 20 min, the total 32p-MLC radioactivity is 
reduced by >90%  (Fig.  2,  C and D).  No 32p-MLC is de- 
tected  in  the  cytosolic fraction  (Fig.  2  D),  indicating  a 
dephosphorylation reaction had occurred rather than dis- 
sociation of 32p-MLC from the cytoskeleton. However, den- 
sitometric  quantitation  of myosin  heavy chain  from  1-D 
PAGE  revealed that  myosin associated with  the  insoluble 
fraction of TSH-treated cells decreased to 65  +  5 % (mean 
+  SEM, n  =  4) of the amount found in control cells. The 
data indicate therefore that "~35 % of the detergent-insoluble 
myosin containing predominantly dephosphorylated MLC 
becomes detergent soluble. In addition to P-MLC, two basic 
(pI 7-8)  major cytosolic phosphoproteins (20 kD)  of un- 
known identity (Fig. 2 B, bracket) are dramatically dephos- 
phorylated after TSH treatment (Fig. 2 D). This concentra- 
tion of hormone was  used  since it increases  intracellular 
cAMP to near maximal levels (37).  MLC is similarly de- 
phosphorylated by treatment of cells with 1 mM dibutyryl 
cAMP (data not shown). 
After treatment of prelabeled cells with 0.2 #M TPA for 
20  min,  the  total  32P-MLC radioactivity  is  reduced  by 
~60% (Fig. 2, E and F), while other proteins of higher mo- 
lecular weight are phosphorylated to a greater extent than 
controls. TPA treatment, like TSH, reduced further the 32p_ 
MLC radioactivity in the cytosolic fraction (Fig. 2 F) com- 
pared with control, which is also consistent with net MLC 
dephosphorylation. Quantitation of detergent-insoluble my- 
osin heavy chain also showed that cytoskeletai myosin was 
reduced to 86 5: 12% (mean 5: SEM, n  =  4) of control cell 
myosin; the lesser degree of myosin "solubilization" com- 
pared with that observed with TSH treatment could correlate 
with the differences in extent of MLC dephosphorylation. 
The two basic,  cytosolic 20-kD proteins are also dephos- 
phorylated after TPA treatment (Fig. 2 F), although as for 
P-MLC, the reduction is not as great as that caused by TSH. 
The dose of TPA used was maximal for effects on phosphory- 
lation, since results were the same at concentrations up to 
1/zM; the inactive 4 ~-phorbol analog of TPA was without 
effect. 
Agonist-Induced MLC Dephosphorylation Is 
Regulated at the Protein Phosphatase Level 
Decreases  in  the MLC  phosphorylation state  induced by 
agents shown in Fig. 2 could result from inhibition of kinase 
The Journal of Cell Biology,  Volume 122, 1993  24 Figure  2.  2-D  SDS-PAGE 
analysis  of cytoskeletal  and 
cytosolic  phosphoproteins 
from  thyroid  cells  treated 
without or with TSH or TPA. 
Cells  pi'elabeled  with  [32p]_ 
phosphate were incubated for 
20 min without (.4 and B) or 
with 40 mU/ml TSH (C and 
D) or 0.2 #M TPA (E and F) 
and  the  cytoskeletal  (.4, C, 
and  E)  and  cytosolic  (B,  D, 
and F) fractions, prepared by 
lysis,  were  subjected  to 2-D 
PAGE  (see  Materials  and 
Methods).  Arrows  point  to 
19- and  21-kD phosphomyo- 
sin  light  chains.  Brackets 
point  to  20-kD  cytosolic 
phosphoproteins.  Below  as- 
terisk is 21-kD region.  Black 
bars on left side  of A repre- 
sent, bottom to top, 31-, 45-, 
and 66.2-kD molecular mass 
markers. 
or stimulation of phosphatase activity. The enzymic pathway 
for net MLC dephosphorylation was examined using the po- 
tent phosphatase 1 and 2A inhibitor, calyculin A. After treat- 
ment of prelabeled cells with 40 mU/ml TSH for 10 min, in- 
soluble 32p-MLC radioactivity is reduced by •50%  (Fig. 3 
B)  compared with control  (Fig.  3  A).  When TSH-treated 
cells  are  incubated  for  an  additional  10  min  at  400  nM 
calyculin A,  insoluble 32P-MLC  radioactivity is  increased 
3.5-fold (Fig. 3  C) compared with control; Fig. 3 D  shows 
the decreased 32p-MLC  after 20 min in TSH alone.  Treat- 
ment of cells with calyeulin A alone for 20 min results in a 
similar increased insoluble 32P-MLC radioactivity and ac- 
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analysis of cytoskeletal phos- 
phoproteins from thyroid cells 
treated without or with TSH 
and  calyculin A.  Cells  pre- 
labeled  with  [32p]phosphate 
were  incubated for  20  rain 
without (A) or with 40 mU/ml 
TSH for 10 rain (B), 10 rain 
with  TSH  and  10 min with 
400 nM calyculin A (C),  or 
20 rain with TSH (D). Cyto- 
skeletal fractions  were then 
prepared by  lysis,  and  sub- 
jected  to  11.5% 1-D  PAGE/ 
autoradiography  (see Mate- 
rials  and  Methods). Arrow 
points to 19- and 21-kD phos- 
phomyosin  light chains. Black 
bars on left side represent 31-, 
45-, 66-, and 92-kD molecular 
mass regions. 
tomyosin contraction determined by rhodamine-phalloidin 
staining (data not shown).  Since MLC is hyperphosphor- 
ylated upon phosphatase inhibition in the presence as well 
as in the absence of TSH, the agonist-induced dephosphory- 
lation process appears to be operating via phosphatase stim- 
ulation and not kinase inhibition. These results are also ob- 
served with dbcAMP and TPA treatments (data not shown). 
A close spatial relationship of a phosphatase with MLC 
could facilitate regulation of the phosphorylation state. Such 
association was examined by incubating [32p]phosphopro- 
reins of the detergent-insoluble cytoskeletal fraction from 
prelabeled,  unstimulated, basal cells in buffer potentially 
conducive to phosphatase activity (50  mM Tris,  50  mM 
NaCI,  1 mM DTT,  5 mM MgC12, 1 mM EGTA,  1.5 mM 
PMSF, pH 7.0). After a  10 rain incubation in this buffer at 
30°C, 32p-MLC is dephosphorylated by 95 %, and although 
the [32p]phosphate content of several other proteins is also 
reduced, most phosphoproteins are not dephosphorylated as 
extensively  as  MLC  under  these  conditions  (data  not 
shown). Inclusion of 20/~M cAMP,  0.1  mM ATP, and 75 
~,g/ml purified A-kinase did not enhance dephosphorylation 
of MLC at shorter incubations periods when the extent of de- 
phosphorylation was less than that achieved after longer in- 
cubations. 
Analysis of  Phosphoamino Acid Sites of  MLCs 
The phosphorylation pattern of MLC isoforms seen in Figs. 
1 and 2 is not limited to a single pI value, similar to that ob- 
served for platelet MLC (28).  Therefore,  either multiple 
sites containing residues of a particular amino acid are phos- 
phorylated and/or different types of amino acids are phos- 
phorylated. Table I  shows that in untreated, basal thyroid 
cells, MLC associated with the detergent-insoluble cytoskel- 
etal fraction is phosphorylated at predominantly threonine 
and serine residues, although phosphotyrosine is detected to 
a minor extent. Treatment of  intact cells with 40 mU/ml TSH 
(as also seen in Fig. 2 C) dramatically reduces phosphoryla- 
Table L  Phosphoamino Acid Analysis of Cultured Dog 
Thyroid Cell MLC 
Percent  Percent  Percent  Percent MLC 
Treatment  P-threonine  P-serine  P-tyrosine  dephosphorylation 
Control*  61  +4  34  +  3  5  :t:  5  - 
TSH (40 mU/ml)*  N.D.  N.D.  N.D.  >95 
TPA(0.2#M)~  59  +  8  33  +  1  8  +  8  56:t:  19 
Cytoskeletal  fractions  from  [32p]phosphate-labeled cells  treated  with  or 
without TSH or TPA were subjected to 2-D PAGE.  The 32p-MLC regions in 
the  gels  were excised  and  the  ~2p-amino acids  from the  hydrolysates  were 
analyzed as described  in Materials and Methods.  Values for percentage 32p. 
amino  acid  and  dephosphorylation  of 32P-MLC are  the  mean  +  standard 
deviation. 
* Five separate experimental determinations. 
t Two determinations. 
§ Three determinations. 
N.D., not determined. 
tion of cytoskeletal MLC resulting in almost undetectable 
levels of phosphoamino acids (Table  I)  which is also ob- 
served  after  in  vitro  dephosphorylation of 32p-MLC as- 
sociated with detergent-insoluble cytoskeletal preparations. 
Treatment with 0.2/~M TPA (as also seen in Fig. 2 E) results 
in a 56  ±  19% reduction in cytoskeletal 32P-MLC, with lit- 
de change in the relative proportions of phosphoamino acids 
compared to control conditions (Table I). 
2-D mapping of tryptic phosphopeptides of both smooth 
muscle and nonmuscle MLC can distinctly resolve the highly 
conserved  peptides  containing  C-kinase  phosphorylation 
sites from the peptide containing the MLCK site at serine 19 
(28).  Fig. 4, A and B show phosphopeptide maps of the 21- 
and  19-kD  32p-MLC tryptic  digests,  respectively,  from 
basal cells. Both MLC species have similar phosphopeptide 
patterns  composed of three  labeled  peptides.  The  major 
radioactive peptide, indicated by the open arrow,  migrates 
furthest upon electrophoresis, relatively little upon chroma- 
tography, and contains both phosphothreonine and phos- 
phoserine residues (Fig. 4 D, lanes I and 2). Considering the 
conserved amino acid sequences of phosphorylated MLC 
tryptic digests, this peptide corresponds to that containing 
phosphothreonine  18  and  phosphoserine  19.  The  minor 
phosphopeptide  above the major spot corresponds to  the 
peptide  containing  a  site(s)  phosphorylated  by  purified 
C-kinase in vitro (not shown), and is reported to contain 
phosphoserine 1 or 2 (28). Radioactivity near the origin rep- 
resents the same tryptic fragment phosphorylated at both 
serine  1 and 2 which is also observed after in vitro phos- 
phorylation of myosin by C-kinase. It should be noted here 
that peptide maps  of 32p-MLC tryptic digests from TPA- 
treated cells showed a decrease in all labeled peptides in&- 
caring that TPA did not decrease phosphorylation at one or 
more sites and concomitantly increase phosphorylation at a 
C-kinase site(s) (data not shown). Fig. 4  C shows the map 
of tryptic phosphopeptides of the 21-kD MLC after hyper- 
phosphorylation induced by the phosphatase inhibitor, caly- 
culin A, shown in Fig. 3. As could be predicted, phosphory- 
lation at serine  1 or 2  alone is no longer apparent,  and a 
concomitant increase in the peptide containing phosphoser- 
ine 1 and 2 is evident near the origin. Also present is the 
phosphothreonine/phosphoserine-containing peptide  (Fig. 
4, open arrows) as well as a new phosphopeptide to the ex- 
treme  right  (Fig.  4,  solid  arrow) containing only phos- 
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mapping  and  phosphoamino 
acid analyses of 21- and  19- 
kD MLC tryptic digests, asp_ 
MLC from detergent-insolu- 
ble cell fractions was isolated 
by  2-D  gel  electrophoresis. 
The  21-  and  19-kD proteins 
were cut  from  the  gel,  di- 
gested with trypsin, and phos- 
phopoptides resolved by elec- 
trophoresis  (left  to  fight) 
followed by chromatography 
(bottom to top) or thin layer 
cellulose plates. Origin is in- 
dicated by (0). A and B show 
autoradiograms  of  32p-pep- 
tides  from  21-  and  19-kD 
MLC  of control basal cells, 
respectively. C shows tryptic 
32p-peptides  of  the  21-kD 
MLC from cells treated with 
calyculin A. Autoradiography 
in C is quantitatively reduced 
relative to A and B to show 
spot resolution. Open arrows 
point to the radioactive spot 
containing both phosphothre- 
onine  (t)  and  phosphoserine 
(s), amino acids which were 
resolved  by  electrophoresis 
(D, lanes I and 2); solid arrow 
in C points to spot containing 
only phosphothreonine  which 
was resolved by chromatogra- 
phy (D, lanes 3 and 4). In D, 
lanes I and 3 show ninhydrin 
staining, and  lanes 2  and  4 
show autoradiography. 
phothreonine (Fig. 4 D, lanes 3 and 4). This additional site 
likely represents phosphorylation  at threonine 9 since a simi- 
lar spot is observed upon in vitro phosphorylation of MLC 
by C-kinase; however, without sequence data, phosphoryla- 
tion at threonine 9 and/or 10 cannot be ruled out at this time. 
Phosphorylation of  MLC in Cultured Dog Thyroid 
Cells Is Caz+  /Calmodulin Independent 
Since MLC is phosphorylated in most systems studied by 
a  specific Ca2+/calmodulin-dependent kinase, the effect of 
various agents known to inhibit this enzyme by interfering 
with calmodulin was studied. Fig. 5  shows 2-D PAGE au- 
toradiograms of cultured dog thyroid cell homogenate pro- 
teins phosphorylated with 0.5 mM [7J2P]ATP for 3 rnin at 
33"C.  In the presence  of 0.1  mM CaCI2 (Fig.  5  A),  the 
MLCs are significantly phosphorylated, and the addition of 
either 5 mM EGTA (Fig. 5 B), 50 ILM W7 (Fig. 5 C) or 50 
/~M W7/5 mM EGTA (Fig. 5 D) has no inhibitory effect on 
the extent of MLC phosphorylation. The same result is ob- 
tained using trifluoperazine (TFP) rather than W7 to inhibit 
calmodulin, or using homogenates of freshly prepared dog 
thyroid follicles (data not shown). In addition, the presence 
of 20/~M cAMP alone or together with 75/~g/ml purified 
A-kinase had no effect on the phosphorylation of MLC, al- 
though the phosphorylation of some other proteins was en- 
hanced (data not shown). 
Since  a  Ca2+/calmodulin-dependent  kinase  has  been 
shown to phosphorylate MLC in cultured fibroblasts, ho- 
mogenates of  dog thyroid fibroblasts were used as an internal 
comparison.  Fig.  6  shows a  1-D  PAGE autoradiogram of 
fibroblast homogenate proteins phosphorylated as above. In 
the presence of 0.1  mM CaC12 a  20-kD protein is signifi- 
cantly phosphorylated (Fig. 6 a), whereas 5 mM EGTA (Fig. 
6 b) or 50 ~M TFP (Fig. 6 c) inhibits phosphorylation by 
90 and 75%,  respectively. Phosphorylation of an ~94-kD 
protein (Fig. 6, small  arrow) is also inhibited by these agents. 
Association of  Kinase Activity with the Cytoskeleton 
Protein ldnase activity and phosphorylated substrates  as- 
sociated with the detergent-insoluble fraction were examined 
and compared using bovine and dog thyroid cells. Unstimu- 
lated, basal cells were lysed, briefly washed with 20 mM 
Hepes, 0.1 mM CaCI2, 5 mM MgC12, 1 mM DTT, 1 t,g/ml 
antipain, 1/~g/ml leupeptin, 1.5 mM PMSE pH 7.6 (kinase 
buffer) at 2°C, and then incubated in this buffer containing 
0.5 mM [~-32p]ATP for 3 min at 24°C.  Fig. 7 A shows a 
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analysis  of thyroid  cell  ho- 
mogenate  proteins  phos- 
phorylated  with  [3,-32p]ATP. 
Homogenates of cultured thy- 
roid ceils were prepared in 20 
mM Hepes, 5 mM MgCI2, 1 
mM DTT, 1.5 mM PMSF, pH 
7.4  0dnase  buffer)  as  de- 
scribed  in  Materials  and 
Methods. Aliquots containing 
0.1  mM  CaCI2 (A),  5  mM 
EGTA (B), 50 /zM W7 (C), 
or  50  /~M  W7  and  5  mM 
EGTA  (D)  were  then  in- 
cubated  with  0.5  mM  (3,- 
32p]ATP (200 cpm/pmol) for 
3 min at 33°C. Samples were 
then prepared for 2-D PAGE. 
Arrows point to phosphomyo- 
sin light chains. 
2-D PAGE autoradiogram of phosphorylated bovine deter- 
gent-insoluble proteins, of which is a  single 20-kD protein 
with  a  pI  value  similar  to  dog  MLC.  Likewise,  dog 
cytoskeletal MLC is phosphorylated (Fig.  7 B),  however, 
unlike that of bovine thyroid cells, P-MLC is the dominant 
phosphoprotein and consists of 19- and 21-kD species. 
MLC Dephosphorylation  Is Accompanied 
by Stress l~ber Disruption 
Basal cells cultured in the absence of TSH contain two spa- 
tially distinct,  well-developed actin stress fiber complexes 
representing much of the detergent-insoluble actin. Fig. 8 A 
shows  rhodamine (rh)-phalloidin  staining  of dorsal  stress 
fibers (Fig. 8 A, arrow) which stretch across the cells in a 
parallel fashion. The zonulae adherens, typical of cultured 
epithelial cells, are also clearly stained with the fluorescent 
label. Fig. 8 B shows rh-phalloidin staining of  thicker ventral 
stress fiber bundles which appear to radiate from focal adhe- 
sion plaques located in cell-substratum contact regions. Af- 
ter treating cells with 40 mU/ml TSH for 30 min,  which 
causes almost complete MLC dephosphorylation (Fig. 2, C 
and D), both the dorsal (Fig.  8  C) and ventral (Fig.  8 D) 
stress fiber complexes are disrupted as determined by unde- 
tectable filamentous rh-phalloidin staining.  Staining of the 
zonulae adherens is not affected by hormone treatment, sug- 
gesting that the F-actin population of this region is resistant 
to the disassembly process. In addition, numerous punctate, 
rod-like structures stain throughout the dorsal cell surface 
(Fig. 8 C), and appear to correlate with disassembly resis- 
tant F-actin of microvilli and pseudopods.  Cell processes 
which frequently extend from ventral regions after TSH or 
dbcAMP treatment (Fig. 8 D) also stain rather strongly with 
rh-phalloidin (Fig. 8 D, black arrows). 
Although TPA treatment causes dissolution of stress fiber 
structure per se (Fig. 8, E and F), F-actin bundles persist in 
the presence of this agent, which could correlate with the 
lesser extent of MLC dephosphorylation compared to TSH 
treatment (Fig. 2). After treating cells with 0.2/~M TPA for 
30 rain,  dorsal  stress  fibers are disrupted  (Fig.  8  E),  al- 
though a  few occasionally remain (Fig. 8 E, white arrow- 
heads). Fig.  8 F  shows the ventral cell region where stress 
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analysis of thyroid fibroblast 
cell  homogenate  proteins 
phosphorylated  with  [V- 
32p]ATP.  Homogenates  of 
cultured  thyroid  fibroblasts 
cells were prepared in 20 mM 
Hepes, 5 mM MgCl2, 1 mM 
DTT, 1.5 mM PMSE pH 7.4 
0dnase buffer) as described in 
Materials  and Methods.  Ali- 
quots  containing  0.1  mM 
CaCI2 (a), 5 mM EGTA (b), 
or 50 /~M TFP (c) were in- 
cubated  with  0.5  mM 
[3,-32P]ATP (200  cpm/pmol) 
for 3 rain at  33°C. Samples 
were  then  prepared  for  1-D 
PAGE. Large and small arrow 
points to 20- and 94-kD phos- 
phoprotein, respectively. 
fibers  appear to  have rearranged and  condensed forming 
large swirls of F-actin bundles that stain intensely with rh- 
phalloidin (Fig.  8 F,, black arrowheads); sheets of F-actin 
which  resemble  lamellipodia,  are  also  observed  in  this 
region. 
The distorted, asymmetric patterns of ventral F-actin stain- 
ing observed after TPA treatment accompany an increased 
protrusive and motile behavior of cells (Fig.  9).  Further- 
more, rh-phalloidin staining of zonulae adbereos F-actin ap- 
pears to be significantly reduced by TPA treatment compared 
to basal and TSH-treated cells (Fig. 8). Fig. 9 shows frames 
from video microscopy of live cells after 0.2 #M TPA treat- 
ment. Significant changes in cell shape and orientation can 
be observed for most cells in the selected field, although in 
particular, note the four cells within the 140 x  80 #m boxed 
area. Perhaps the most dramatic changes occur during the 
first 20 min after TPA addition (Fig. 9 b), when cells retract 
and begin protruding.  Dorsal  cell membrane regions can 
also be found to bleb and ruffle which probably correlates 
with stress fiber disruption in this vicinity. Even after 80 rain 
(Fig 9  e), cells continue to reorient with respect to their 
neighbors. Note particularly the cell indicated by the black 
arrow which expands and extends from a horizontally elon- 
gated to vertical position (Fig. 9, a-eL 
TSH and TPA Induce a Reorganization  of Cytoskeletal 
Myosin After Stress Fiber Disruption 
As shown in Fig. 2, A and B, most of the phosphorylated 
MLC is associated with the detergent-insoluble fraction in 
basal  cells.  Indirect  immunofluorescence of this  fraction 
with antimyosin reveals that myosin is localized on both dor- 
sal and ventral stress fibers (Fig. 10 A) since the staining pat- 
tern reflects that observed with rh-phalloidin shown in Fig. 
Figure 7. 2-D SDS-PAGE  analysis of  bovine and canine thyroid cell 
cytoskeletal proteins phosphorylated with  [qt-32P]ATP. Cultured 
bovine (A) or canine (B) thyroid cells were lysed and cytoskeletons 
washed with 20 mM Hepes, 5 mM MgCl2, 1 mM DTT, 1.5 mM 
PMSE pH 7.4 (kinase buffer) at 2°C as described in Materials and 
Methods. Cytoskeletons were incubated in kinase buffer contain- 
ing 0.1 mM CaC12 and 0.5 mM [3,-32p]ATP (200 cpm/pmol) for 
3 min at 24°C. Samples were then prepared for 2-D PAGE. Arrows 
point to 20-kD phosphomyosin light chain (A), and 21- and 19-kD 
phosphomyosin light chains (B). 
8, A and B. After a 30-min treatment of cells with 40 mU/ml 
TSH, antimyosin staining of stress fiber complexes is not ob- 
served, consistent with stress fiber disruption shown in Fig. 
8, C and D. However, myosin appears to reorganize and as- 
sociate with a fine, detergent-insoluble filamentous network 
throughout the cytoplasm (Fig.  10 B). In Fig.  10 C, after a 
30-min treatment with 0.2/~M TPA, antimyosin also stains 
a filamentous network in many cells which appears similar 
to that observed after TSH treatment.  Furthermore, after 
TPA treatment, a  redistribution of myosin also appears to 
parallel that of F-actin in the ventral region shown in Fig. 8 
D; myosin is associated with fine filamentous sheets as well 
as large, twisted bundles (Fig. 10 C, open arrows) in this cell 
region. 
TSH, but not TPA, Induces Phagocytosis 
of  Latex Beads 
The phagocytotic capacity of cultured thyroid cells in the 
presence of 1/zm carboxylate-modified latex beads was ex- 
Deery and Heath Myosin Light Chain Dephosphorylation and Phagocytosis  29 Figure 8. Rh-phalloidin  staining  of F-actin in cultured thyroid cells.  Ceils in 5H media alone (control)  (A and B), were either incubated 
with 40 mU/ml TSH (C and D), or 0.2 ~M TPA (E and F) for 30 min at 37°C.  After treatment,  cells were fixed, lysed, and stained  with 
rh-phalloidin  as described in Materials  and Methods. In A, C, and E the microscope was focused on the dorsal cell region; in B, D, and 
F,, focus was on the ventral region. Black arrow in A points to some dorsal stress fibers of untreated,  control cells; TSH treatment abolished 
dorsal (C) and ventral  (D) stress  fibers,  while the black arrows in (D) point to concentrated actin staining  within extended  ventral cell 
processes.  White arrowheads in (E) point to a few remaining dorsal stress fibers after TPA treatment,  while the black arrowheads  in (F) 
point to some of the ventral  actin ribbon-like  structures.  Bar,  10/~m. 
amined  after  30-rain treatments  without and with 0.2  #M 
TPA or 40 mU/ml TSH. By scanning EM,  control cultures 
revealed an intact monolayer of  predominantly flat cells with 
a variable density of small microviUi (Fig.  11, A). Occasion- 
ally,  small  ruffles  and pseudopodial  protrusions  were  ob- 
served on some cells.  Upon TPA treatment Fig.  11 B), the 
cells  rapidly retracted  from their neighbors,  became elon- 
gated, and extended over and under each other as also indi- 
cated by video microscopy (Fig. 9). A gross spatial reorgani- 
zation or migration of  cells is depicted in Fig. 9 B. Typically, 
the  dorsal  surfaces  were  ruffled  and  elevated,  and  large 
knobby  protrusions  were  apparent  at  the  cell  periphery; 
microviUi number and density appeared similar to those of 
control cells.  TSH-treated cells (Fig.  11,  C-F), in contrast 
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video  microscopy of thyroid 
cell shape changes and motil- 
ity induced by TPA. A con- 
fluent cell  monolayer in  5H 
media  was  treated  at  37°C 
with 0.2 #M TPA; a field was 
immediately  selected  and 
recorded  by  video  micros- 
copy. Images shown were pro- 
duced from the tape by a video 
printer at  1.5 (a), 20 (b), 40 
(c), 60 (d), and 80 (e) min af- 
ter  TPA  addition.  Constant 
140  x  80  #m  areas  (white 
boxes) were marked as a refer- 
ence and contain four particu- 
larly active cells; black arrow 
in upper fight comers points 
to a cell undergoing re,  orien- 
tation. 
to TPA, developed a  more rounded rather than elongated 
morphology, and retracted less frequently from their neigh- 
bors. Smooth-surfaced pseudopodial protrusions and ruffles 
were  seen extending from the central regions and  lateral 
margins (Fig.  11, E and F). Latex beads, shown in Fig.  11, 
C  and  D  (black arrow),  were commonly associated with 
these structures (Fig. 11, C and D, white arrowheads) which 
are probably the main sites of phagocytosis. 
Fig. 12 A shows a transmission EM micrograph of a verti- 
cal section through a basal cell subjected to latex beads for 
30 min at 37°C. Microvilli are present on the dorsal surface 
(Fig. 12 A, arrowhead). The section shows a prominent bun- 
dle of F-actin running horizontally beneath the dorsal sur- 
face, corroborating the pattern seen in cells stained with rh- 
phalloidin (Fig.  8 A).  Periodic densely stained foci within 
the filaments (Fig. 8 A, open arrows) are present which are 
likely  to  be  sites  of  F-actin  bundling  proteins  such  as 
a-actinin;  filamin and myosin are probably located in be- 
tween the foci (32). Quantitation of vertical, 1-#m-thick sec- 
tions of cells (cell region) and intracellular beads therein by 
light microscopy (Fig.  13) shows that 6% of cell regions ex- 
amined contained beads; only a few regions had more than 
four beads, and there were a couple above 8. However, after 
stimulating cells for 30 min with 40 mU/ml TSH (Fig.  12 
B), the number of microvilli per surface area appeared to in- 
crease, pseudopods and complex phagocytic structures were 
observed (Fig.  12 B, open arrow), and 19% of cell regions 
examined contained significantly more beads (up to 25 per 
region) than controls (Fig. 13). Stress fiber bundles were not 
observed by EM under this condition, which corroborated 
their absence using rh-phalloidin (Fig. 8, B and C). While 
treating cells with 0.2 #M TPA for 30 min also caused dorsal 
stress fiber disruption and surface ruffles, it did not promote 
pseudopod formation (Fig.  12 C), and only 9% of the cell 
regions contained beads;  relatively few regions had more 
than eight beads (Fig. 13). The small increase in bead uptake 
versus control could be due to bead entrapment and subse- 
quent ingestion by the ruffled dorsal cell surface shown in 
Fig. 11 B. Microvilli at the dorsal surface (Fig. 12, A and C, 
black arrowheads) were similar to those of untreated control 
cells,  and bundles of F-actin could be seen parallel to the 
ventral plasma membrane (open arrows). 
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myosin in cultured thyroid cells. Cells in 5H media alone (control) 
(A), were either incubated with 40 mU/ml TSH (8), or 0.2 ~M TPA 
(C) for 30 min at 37°C. After treatment, cells were lysed, fixed, 
and stained with myosin antibody and rh-conjugated second anti- 
body as described in Materials and Methods. In untreated basal 
cells (,4), myosin  localizes on parallel, dorsal stress fibers and radi- 
ating ventral bundles; TSH (8) and TPA (C) induce a rearrangement 
of  this staining pattern. Open arrows in C point to myosin  antibody 
staining of some twisting ribbon-like structures which also stain 
with Rd-phalloidin (see Fig. 8 F) in the ventral cell region. Bar, 
10/zm. 
Discussion 
This study has identified 19-  and 21-kD  species of MLC 
which  are  phosphorylated  at  both  threonine  and  serine 
residues  by a  Ca2+-independent  kinase(s)  associated with 
the detergent-insoluble cell fraction of primary thyroid cell 
cultures from dog. Based on tryptic peptide/phosphoamino 
acid analyses, much of the phosphorylation corresponds to 
the threonine and serine sites phosphorylated by Ca2+/cal  - 
modulin-dependent MLCK. Treatment of cells with TSH, 
dbcAMP or the phorbol ester,  TPA,  decreases the phos- 
phorylation state of MLC which can be blocked and reversed 
by the phosphatase inhibitor, calyculin  A. Relatively specific 
phosphatase activity for MLC is also associated with the in- 
soluble, cytoskeletal fraction. There is a correlation between 
MLC dephosphorylation, the disruption of stress fibers, and 
the subsequent development of a different actomyosin net- 
work following either TSH or TPA treatment of cells. Al- 
though both agents apparently induce a  reorganization of 
F-actin and myosin H upon disruption of stress fibers in the 
dorsal cell region, phagocytosis of latex beads in this cell re- 
gion is induced primarily by TSH through a cAMP-mediated 
pathway. 
MLC in the cultured thyroid cells, identified by antimyosin 
immunoprecipitates, is in a phosphorylated state, and is as- 
sociated with the Triton X-100-insoluble cytoskeletal frac- 
tion under resting, basal conditions, which contrasts myosin 
II of  other nonmuscle cells such as platelets (17). In unsfimu- 
lated platelets, >90% of the MLC is detergent soluble and 
is not phosphorylated. Elevation of intracellular Ca  2+ by the 
agonist, thrombin, or ionophore induces MLC phosphoryla- 
tion via Ca2÷/calmodulin-dependent MLCK, and thus pro- 
motes the formation of '~activated" actomyosin complexes, 
which participate in cell contraction and secretion. Stimula- 
tion of thyroid cells by the agonist, TSH, on the other hand, 
increases intracellular cAMP,  which induces disruption of 
F-actin bundles and consequent changes in cell shape (37, 41, 
52, 55); under these conditions MLC dephosphorylation is 
observed.  These effects are reproduced by cAMP analogs, 
implicating an A-kinase mediated process.  MLC dephos- 
phorylation induced by cAMP  in fibroblasts is  also  cor- 
related with disruption of stress fibers and cell rounding 
(33). It is interesting in thyroid cells, that subsequent to de- 
phosphorylation of MLC and stress fiber disruption, deter- 
mined by rhodamine-phalloidin fluorescence, much of the 
myosin (and actin) remain detergent-insoluble (,~55-75 %) 
as determined from one dimensional PAGE analysis. Indirect 
immunofluorescence with myosin antibody reveals  a  fine 
filamentous network throughout the cytoplasm, suggesting 
that cAMP mediates a reorganization rather than extensive 
dissolution of actomyosin complexes. 
The protein kinase C-stimulating phorbol ester, TPA, also 
induces thyroid MLC dephosphorylation (~60 %) and stress 
fiber disruption, however, this agent does not reproduce TSH 
or dibutyryl cAMP effects on cell morphology and F-actin 
reorganization.  Similar to  that observed  following TSH- 
treatment, most (>70%) of the actomyosin remains deter- 
gent-insoluble after TPA treatment. This is corroborated by 
the organization of F-actin into thick ribbon-like structures 
and sheets predominantly located in the ventral cell region, 
also observed in other cultured epithelial cells (29, 41, 44). 
These aggregates stain with antimyosin, and could contain 
the MLC fraction which is not dephosphorylated by TPA 
ueatment. While TPA-induced phosphorylatiun of MLC has 
been implicated in C-kinase mediated platelet activation (2, 
28),  there is no evidence for such phosphorylation in this 
thyroid cell system. It is plausible that these prominent yen- 
The Journal of Cell Biology, Volume 122,  1993  32 Figure 11. Scanning electron micrographs showing cell shape changes and surface features of cultured thyroid cells. (A) Control culture 
shows a monolayer of polygonal cells with variable densities of microvilli. (B) Cells treated with TPA for 30 min in the presence of 0.04  % 
suspension of carboxylate-latex beads shows a dramatic chan~e in shape. Beads adhere to the cell surface but phagocytotic structures are 
rarely present. (C-F) Cells treated with TSH for 30 rain in the presence of beads. In C, beads adhere to the cell surface (black arrow), 
and small ruffles and pseudopodial structures are present. Beads are trapped by ruffles (white arrowhead), and an example of bead entrap- 
ment (white arrowhead) is shown at higher magnification in D. Examples of the surface ruffles and pseudopods extended upon TSH treat- 
ment are shown in E and F; note the dramatic cell retraction associated with the development of dorsal protrusions (F). 
tral actomyosin complexes participate in the shape changes 
and motility of cells treated with TPA, which differ from 
phagocytic activities  observed with  TSH.  However,  TPA 
may induce the formation of a myosin network in the dorsal 
cell region which is somewhat similar to that in TSH-treated 
ceils. 
Unlike the classic Ca~+/calmodulin-dependent  phosphor- 
ylation of MLC in smooth muscle and many nonmuscle cells 
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tured  thyroid  cells  exposed  to 
carboxylate-latex beads. Confluent cell 
monolayers in 5H media were incubated 
with  a  0.04%  suspension  of  I  pm 
carboxylate-latex beads for 30 min ei- 
ther  without  agents  (control)  (A),  40 
mU/ml TSH (B), or 0.2 pM TPA (C), at 
37°C,  and  prepared  for  transmission 
EM  as  described  in  Materials  and 
Methods. In A, black arrowhead points 
to dorsal surface and protruding micro- 
villi;  beneath  the  plasma  membrane, 
open arrows point to a parallel  bundle of 
F-actin  containing  periodic,  densely 
stained foci. B shows a region of a TSH- 
treated cell with a dorsal phagocytotic 
structure  (arrow)  and  several ingested 
latex  beads  in  the  absence  of  stress 
fibers. In C, black arrowheads point to 
dorsal surface and microvilli of a TPA- 
treated cell. Arrows point to a parallel 
bundle  of  F-actin  above  the  ventral 
membrane close to which is a coated pit 
(open arrowhead). L, lysosome; B, latex 
bead. Bars, 0.3/~m. 
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NUIdBER  OF BEADS PER CELL REGION 
Figure 13. Quantitation  of latex bead ingestion  by cultured thyroid 
cells. Thick (1 #m) sections were cut vertically 70/~m apart from 
cell cultures (untreated  controls, TSH or TPA treated) also prepared 
for transmission EM in Fig. 12.2,500 cell regions, each being from 
a different cell, were examined for the three conditions, and intra- 
cellular beads were scored u3ing phase contrast microscopy; a cell 
region is a vertical, 1-/~m-thick  section of a single cell. The total 
number of beads counted per condition was: 308 (control),  1,869 
(TSH), and 681 (TPA). 
(1, 4, 31, 56), phosphorylation of dog thyroid MLC does not 
appear to involve a Ca2+-dependent kinase(s). In support of 
this, both EGTA and calmodulin inhibitors have little to no 
effect on  32p-labeling  of  MLC  in  cell  homogenates  in- 
cubated with [~/-32p]ATP. Similar phosphorylation activity 
is also found associated with the Triton-insoluble cytoskele- 
tal fraction, suggesting a close spatial relationship between 
kinase  and  MLC.  MLCK  has  been  localized  by  im- 
munofluorescence on  the  microfilament complex  in  3T3 
fibroblasts (20).  Proteolytic conversion of Ca2+-dependent 
kinase to a  Ca2+-independent  form does not appear to be 
responsible for the phosphorylation characteristics in thy- 
roid ceils since protease inhibitors are present, and no such 
alteration  is  evident  in  the  Ca2+/calmodulin-dependent 
phosphorylation of a single 20-kD MLC species in thyroid 
fibroblast homogenates under the same buffer conditions. In- 
terestingly, 32p-MLC labeled in intact, basal thyroid ceils 
contains a  significant amount of phosphothreonine which 
has not typically been reported in other cell systems, al- 
though  Ca2+-independent  threonine  phosphorylation  has 
been reported for brain MLC, which also is present in two 
species (36).  Furthermore, in vitro phosphorylation of tyro- 
sine has been observed in smooth muscle MLC (19),  and 
phosphotyrosine is detected to a minor extent in thyroid. 2-D 
tryptic peptide mapping and phosphoamino acid analysis in- 
dicate that the major 32p-peptide corresponds to the phos- 
phopeptide containing the classic MLCK threonine 18 and 
serine 19 sites; there is no indication that serine 19 alone is 
phosphorylated to a significant extent in this study. Analyses 
of the two minor phosphopeptides indicate that they cor- 
respond to the peptides containing phosphoserine 1 or 2, and 
1 and 2 (28). While TPA treatment of thyroid cells does not 
enhance C-kinase phosphorylation at these sites, the phos- 
phorylation at such sites in addition to the MLCK sites, 
particularly after phosphatase  inhibition by  calyculin A, 
strongly suggests that various kinases (e.g., cyclin-p34  ~2) 
can act on MLC in concert. Interestingly, a 20-kD MLC spe- 
cies is phosphorylated by a Ca2÷/calmodulin-dependent ki- 
nase in preparations from bovine thyroid tissue (51),  and 
only a single species is observed in cultured bovine thyroid 
cells. It therefore appears that different molecular compo- 
nents and regulatory mechanisms exist, even among thyroid 
cytoskeletal systems. 
One potential mechanism for the TSH-induced, cAMP- 
mediated decrease in the phosphorylation state of MLC is 
phosphorylation and  subsequent  inhibition of MLCK by 
A-kinase, which would result in net MLC dephosphorylation 
via phosphatase activity. This mechanism appears to operate 
in regulating the phosphorylation state of MLC in retinal 
cones when intracellular levels of cAMP are elevated (9). An 
even more definitive, direct demonstration of phosphoryla- 
tion and inhibition of MLCK via A-kinase has been reported 
in fibroblasts (33). However, such a pathway does not appear 
to exist for the Ca2+-independent MLCK in the dog thyroid 
system. MLC phosphorylation in cell homogenates or cyto- 
skeletal  preparations  is  not  affected by  the  inclusion  of 
cAMP with or without purified A-kinase, even though phos- 
phorylation of several proteins was enhanced.  Thus,  this 
MLCK appears to lack both regulation by Ca2+/calmodulin 
as well as an inhibitory A-kinase phosphorylation site. 
Dephosphorylation of MLC induced by TSH (via cAMP) 
or the phorbol ester, TPA, appears to result from enhanced 
phosphatase  activity, since  MLC can be  hyperphosphor- 
ylated upon addition of the phosphatase 1 and 2A inhibitor, 
calyculin A, after treatment of cells with these agents. Fur- 
thermore, calyculin A treatment alone increases MLC phos- 
phorylation severalfold causing extensive actomyosin and 
cell contraction. Interestingly, phosphatase type-1 has been 
shown to localize on stress fibers and dephosphorylate MLC 
in fibroblasts (16). Phosphorylated MLC associated with the 
cytoskeletal fraction of Triton-lysed thyroid cells can be 
readily dephosphorylated (>90%) upon incubation in a Tris 
buffer system. This nearly complete and relatively specific 
dephosphorylation  reflec,b%  that  observed  in  intact  cells 
treated with TSH, suppo~  the involvement of the same 
phosphatase(s). It is possible that stimulated phosphatase ac- 
tivity occurs by either direct phosphorylation of  the phospha- 
tase or inactivation of an inhibitor via A-kinase-mediated 
phosphorylation.  For example,  a  protein phosphatase  1M 
associated with myosin has been identified in rabbit skeletal 
muscle, and is inhibited by inhibitor-2; glycogen synthase ki- 
nase 3-mediated phosphorylation of inhibitor-2 inactivates 
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the rate and extent of thyroid  MLC dephosphorylation was 
not  affected by  the  addition  of ATP,  cAMP  and  purified 
A-kinase, suggesting that the regulatory element(s) is either 
not associated with the detergent-insoluble cytoskeletal frac- 
tion or is altered (data not shown). Inappropriate buffer con- 
ditions could also account for the lack of hypothetical cAMP- 
mediated stimulation of phosphatase activity in vitro. 
In the present study, distinct differences relative to various 
other cell systems are observed in the state of cytoskeletal 
MLC phosphorylation and its regulation in response to cell 
agonists.  MLC phosphorylation at serine 19 and threonine 
18 by Ca2÷/calmodulin-dependent  MLCK in smooth muscle 
or  many  nonmuscle  cells  correlates  well  with  agonist- 
induced actomyosin contraction and subsequent functional 
events  such as changes  in cell shape or secretion.  On the 
other hand, phagocytosis of latex beads induced by TSH and 
cAMP analogs, is associated with MLC dephosphorylation, 
apparently via A-kinase mediated stimulation of phosphatase 
activity.  Although stimulation of C-kinase by TPA treatment 
might cause similar MLC dephosphorylation and actomyo- 
sin rearrangement  in the dorsal cell region, it does not pro- 
mote significant phagocytic  activity.  MLC dephosphoryla- 
tion  therefore  appears  to  play  at  least  a  partial  role  in 
structural  rearrangements  of the actin/myosin-II cytoskele- 
ton (16, 33); these altered complexes could provide a more 
flexible environment for cAMP-induced endocytotic struc- 
tures and functions. Recently, long term exposure of cultured 
thyroid  cells to 3'  interferon has  been  reported to reduce 
F-actin cytoskeletal  complexes,  part of which may  be  in- 
volved in microvilli and  pseudopod structure  since a dra- 
matic decrease is observed in both microvilli number and 
TSH stimulation of pseudopod formation (6).  Considering 
the consensus in the literature that MLC phosphorylation by 
MLCK  is required for actomyosin contraction  (3,  13,  31, 
54),  our observations  of MLC  dephosphorylation  do  not 
implicate an "active" role for myosin-II in pseudo-podial ac- 
tivities. It is possible, however, that localized actin polymer- 
ization, phosphorylation of myosin-I, and membrane inter- 
actions between F-actin and myosin-I (39) operate in thyroid 
phagocytosis. 
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